Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00509-4/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_acc25&_hsenc=p2ANqtz-9NizHG8ytCgGGUS9NbbrQvkziZOFYS7b5Hqr9m48czEh5R5G5eD9AnYQnANY5a_BS9b6qnZU8qY4Jbn6LXl4D7Zcr-vA&_hsmi=354063385&utm_content=354063385&utm_source=hs_email